The effects of low doses of eucalyptus oil (EO) were studied on the surface properties of phospholipid suspensions as exogenous surfactants, by in vitro analysis using a pulsating bubble surfactometer and a Wilhelmy balance. Survanta, ALEC and Exosurf, commonly used surfactants in therapy of respiratory distress syndrome were used as controls for comparison. The test surfactants, in Ringer's lactate at 1%, were pulsated at 40 cpm in the surfactometer. EO caused a significant improvement of adsorption of the surfactants. In the case of the binary mixture of dipalmitoylphosphatidylcholine and phosphatidylethanolamine (2:3), EO significantly improved the adsorption, stability and minimum surface tension obtained. This combination performed better than ALEC and Exosurf and was comparable to Survanta with respect to minimum surface tension attained. The re-spreading of a surface excess film of this mixture in a Wilhelmy balance was higher than that of ALEC and Exosurf. The ultrastructure of the EO enriched surfactants using cryogenic scanning electron microscopy showed easy facturability and formation of open membranous structures, which could have been associated with the improved surface activity.
Introduction
Pulmonary surfactant is a complex mixture of a variety of saturated and unsaturated phospholipids, neutral lipids and surfactant specific proteins SP-A, B, C and D (Wilkinson, 1993) which lower the surface tension at the air-alveolar interface of the lungs. Respiratory distress syndrome of neonates is most often due to a developmental deficiency of pulmonary surfactant along with an immature structure of the lungs (Avery, 1959) . The predominant phospholipid in lung surfactant is dipalmitoyl phosphatidylcholine. It is capable of achieving near zero surface tension during monolayer compression but cannot function alone as an effective replacement surfactant due to its poor adsorption and re-spreading. Most surfactants available commercially vary widely in their composition and biophysical properties. Protein-free surfactants have a relative disadvantage of poor re-spreading when compared to their natural counterparts. The surfactant specific proteins SP-A, B and C are responsible for the rapid adsorption and re-spreading of natural lung surfactants (Creuwels et al., 1997) . However, immunogenic and cost considerations make the search of an effective and affordable artificial protein-free surfactant worthwhile in spite of their relative lower efficacy. In Exosurf, the addition of hexadecanol helps to partially overcome this disadvantage of protein-free surfactants by improving the adsorption and re-spreading of the base phospholipid namely dipalmitoyl phosphatidylcholine (Yu and Possmayer, 1993) . Certain other natural oils and alcohols could perhaps be used instead of hexadecanol as respreading agents and are the subject of the present study.
One such natural oil is eucalyptus oil (EO) which is commonly used as an expectorant in chronic bronchitis (Gennaro, 1985) . The efficacy of EO in chronic bronchitis was documented by Siurin (1997) with beneficial effects in a study of 150 patients with chronic bronchitis. However, very few studies have described the performance of this oil as a possible surfactant in respiratory distress syndrome. Zanker et al. (1980) had evaluated the surfactant like effects of commonly used remedies for colds including EO. They found a decrease in surface tension at an airwater interface and improved lung compliance in in vivo animal studies with EO. The present study evaluates the in vitro performance of EO as a component of phospholipid based surfactants.
The aims of the present study are to compare the surface properties of different phospholipid solutions with or without the addition of EO and to approach the clinical issue of obtaining a protein-free effective surfactant.
Materials and methods
1,2 dipalmitoyl phosphatidylcholine (DPPC, abbreviated here as PC), palmitoyloleoyl phosphatidylethanolamine (PE) and palmitoyloleoyl phosphatidylglycerol (PG) were purchased (all \ 99% purity) from the Sigma Chemical Co. Calcium chloride was obtained as \ 98% purity from Qualigens Fine Chemicals-Glaxo, India. Sterile Ringer's lactate solution was obtained from Albert David Ltd., India. Exosurf Neonatal, Survanta and ALEC were obtained as kind gifts from Burroughs Wellcome Co., Ross Laboratories, and Britannia Pharmaceuticals, UK, respectively. Technical grade EO, having specific gravity 0.9159 0.005 at 25°C, was purchased from Gopaldas Visram and Co., India. Sterile distilled water and sterile normal saline were used, as supplied, for reconstitution of Exosurf and ALEC. Other chemicals used in the experiments were HPLC grade chloroform and acetone (Qualigens Fine Chemicals-Glaxo, India). Chloroform was used as the spreading solvent.
We studied the effects of EO at low doses (1 part oil to 9 parts of phospholipid v/v), on the surface properties of phospholipid monolayers by in vitro analysis using a pulsating bubble surfactometer. This instrument tests the dynamic surface properties of surfactants at a spherical interface and can be pulsated at high speeds. This would be relevant to the lung surfactant system as pulsation at a high speed of 40 cpm would correspond to the respiratory rate of neonates (Schubring et al., 1976; Yu and Possmayer, 1993 ) and also to the frequency of ventilator settings used for neonates (Koyabashi et al., 1990) . The minimum surface tension, static surface tension at a bubble of maximum sizeas a measure of the adsorption to an air-liquid interface, and stability index of liposomal suspensions of the main phospholipids of pulmonary surfactant and their binary mixed films, in the ratio of 2 parts of PC with 3 parts of PE or PG, forming the mixtures PCPE and PCPG, respectively, are studied both in the absence and in the presence of eucalyptus. The surfactants in the presence of EO are referred to PCEO, PEEO, PGEO, PCPEEO, and PCPGEO. EO was added in the ratio of, 1 part of EO (2 ml) to 9 parts of the phospholipid (single/ mixed). The performance of the test formulations with EO was compared with that of three different commercial surfactants -Survanta, ALEC and Exosurf. This was supplemented by the study of the performance of EO enriched surfactants on the re-spreading of phospholipid monolayers using a Wilhelmy balance. The ultrastructure of liposomal suspensions of the surfactant formulations with eucalyptus were also studied in an attempt to analyze the structural changes, if any, which could explain the effects of EO.
Pulsating bubble surfactometer experiments
All the test surfactant formulations were studied in the form of phospholipid suspensions in Ringer's lactate (a polyelectrolyte solution containing 2 mM calcium and buffered to a pH of 7.4). Ringer's lactate was used due to its similarity to the chemical composition of the alveolar fluid as studied by Nielson (1986) . Thin films of 20 ml of single or mixed phospholipid solution in chloroform (concentration 50 mg/ml) were formed and the solvent was allowed to evaporate under nitrogen gas for half an hour. EO was added in the ratio of, 1 part of EO (2 ml) to 9 parts of the phospholipid (single/mixed). The final concentration of the phospholipid-oil mixture in the liposomal suspension was 1%. The thin film, after evaporation of the solvent, was dispersed in 100 ml of Ringer's lactate, shaken by hand and then left undisturbed at room temperature for 12 h to allow formation of liposomes by hydration (Yu and Possmayer, 1993) . The therapeutic surfactants were tested after reconstitution in the form recommended for clinical use in a concentration of 1 mg phospholipid per ml. Control experiments were performed using EO suspended in Ringer's lactate in a concentration of 1%.
All samples were tested at 37°C in a pulsating bubble surfactometer (Surfactometer, Electronetics Corp.). This instrument and its use in dynamic surface property evaluation were first described by Enhorning (1977) . Briefly, a disposable plastic chamber is loaded with 25 ml of the test sample. The capillary of this chamber serves as an airway for bubble formation. A thermoregulated water bath surrounds the chamber. The bubble size can be changed by manual control from minimum size having radius R min = 400 mm (minimum surface area A min = 201.1×10 4 mm 2 ) to maximum size having radius R max = 550 mm (maximum surface area A max = 380.3×10 4 mm 2 ). The bubble can be pulsated between these two sizes at frequencies upto 100 cpm. There is a 47% reduction in area when the bubble changes size from R max to R min .
The pressure gradient across the bubble (DP) is measured with the help of a precision transducer having a pressure range of 0-10 Torr and sensitive to very low volume displacements (0.04 ml/cm water). The surface tension at the air-liquid interface (g) is then calculated at minimum and maximum bubble size of R min and R max , respectively, in accordance with the law of Laplace as applied to spheres (DP min = 2g min /R min and DP max = 2g max / R max ). The bubble was cycled in automatic mode between R min and R max at 40 cpm for 10 cycles and the minimum and maximum surface tension were measured as surface tension at R min and R max , respectively, during pulsation at 40 cpm. Cycling was stopped at R min and the bubble was expanded manually to R max and held static for 10 sec. The static surface tension was measured. This gives an indication of the adsorption of the surfactant at the air -liquid interface of the bubble. A correction factor was applied to the static surface tension at R max by multiplication with the factor 0.055/0.040 (equal to the maximum radius/minimum radius in accordance with Putz et al. (1994) . This was done to compensate for the error arising due to the assumption by the inbuilt program of the pulsating bubble surfactometer of a minimum radius during start of static measurements by default. Stability index (SI) was calculated as SI= 2(g max − g min )/(g max + g min ) at 40 cpm (Clements et al., 1961) . 40 cpm was chosen as the frequency of oscillation as it corresponds to the neonatal respiratory rate (Yu and Possmayer, 1993) and is the frequency which is used clinically in ventilator settings for a neonate of respiratory distress syndrome (Koyabashi et al., 1990) .
Statistical analysis of the effects of the additives was done by the Mann-Whitney U test using PB0.05 as the cut off level for significance.
Wilhelmy balance experiments
Dynamic surface pressure-area (p-A) isotherms of solvent spread interfacial films were measured with a Wilhelmy surface balance (LB 5000, KSV Instruments, Finland). Highly pure triply de-ionized water (Milli-Q UV Plus System, Millipore Corp.) and acetone were used in all balance cleaning procedures. For subphase formation, sterile Ringer's lactate solution, which contains in mEq/ L Na + 131, K + 5, Ca ++ 4, bicarbonate as lactate 29 and Cl − 111, was used after adjusting to a pH of 7.4 by adding concentrated NaOH drop-wise.
Surfactants were dissolved in chloroform to a concentration of 1 mg/ml and the solution was spread drop-wise from a syringe at the air -water interface under surface excess conditions. This refers to a high initial surface concentration where the amount of surfactant spread was greater than that required for a monolayer coverage (15 A , 2 / molecule). For studying the effect of EO, 1 part of EO (Gopaldas Visram & Co., India) was added to 9 parts of the chloroform solution of the phospholipid before spreading. All experiments were carried out at a body temperature of 37 90.5°C. A time span of 10 min was allowed for solvent evaporation before commencing dynamic cycling. Surface pressure (the difference in the surface tension of the interface without and with surfactant) was monitored continuously from the force on a sand-blasted platinum slide. Seven successive cycles of compression/expansion at the interface were recorded between maximum and minimum areas of 772.5 and 193.1 cm 2 (compression ratio 4:1) at a constant speed of 1.2 cpm. The compression ratio of 4:1 is much higher than that found in normal respiratory cycles. However, this ratio was used in the present study in order to obtain information regarding the re-spreading capability of the surfactants. This was done by comparison of collapse-plateau ratios, which could be obtained only on maximum compression of the films past collapse. The speed of 1.2 cpm was the highest possible by the Wilhelmy balance used.
Dynamic re-spreading was characterized by collapse plateau ratio criteria of Turcotte et al. (1977) . This parameter cannot be easily judged by a pulsating bubble surfactometer. Hence, experiments were conducted on a Wilhelmy balance to study the re-spreading of PCPEEO in comparison with the commercial surfactants. On a given p-A compression curve, a vertical line is drawn at the point of steepest slope and a horizontal line is drawn at the post-collapse region. The distance from the intersection of these lines to the end of the compression stroke is defined as the collapse plateau length. The re-spreading ratio is given by the ratio of the lengths of these plateaus for the seventh and first cycles. A ratio of 1 indicates complete re-spreading and of 0 indicates no respreading. Fig. 1 schematically represents the method of calculation of this ratio.
Cryogenic scanning electron microscopy experiments
All samples were tested as liposomal suspensions of 1% concentration as used for the pulsating bubble surfactometer study. The technique used for sample preparation for cryogenic scanning electron microscopy was developed by Bhadriraju and Bellare (1993) . In this cryo-technique, a thin layer of the sample was sandwiched between two copper meshes that were fixed on two copper plates. The copper plates used were of 0.1 mm commercial grade copper and the meshes were squares of : 3× 3 mm 2 . One of the copper plates was L-shaped to facilitate fracture of the sample inside the airlock chamber of the microscope. The sandwiched sample was then plunged rapidly into liquid nitrogen kept at − 196°C. Samples were kept in liquid nitrogen for 30 min and then transferred onto the cryo-stage of the scanning electron microscope (JEOL 6400 SEM). The samples were then stabilized in the airlock chamber fracture-stage and then freeze fractured by removing the L-shaped copper plate with the microscope's fracture knife. The fractured sample together with cryo-stage was then transferred to the specimen chamber of the microscope. Both the fracture-stage in the airlock chamber and the imaging stage in the specimen chamber of the microscope were maintained at − 130°C. The sample was imaged at an accelerating voltage of 5 kV and a scanning probe current of 10 − 9 A, working distance of 27-32 mm and magnifications between 1000× and 4000× . Fig. 2 shows the minimum surface tension at 40 cpm for the test formulations, without and with EO. The stability indices are compared in Fig. 3 and the values of static surface tension on adsorption are compared in Fig. 4 . EO in buffer, without any phospholipids, adsorbed to a surface tension of 35 9 2 mN/m and on compression reached a minimum tension of 30 9 1 mN/m.
Results
The attainment of low static surface tension values indicates the formation of a monolayer film of the surfactant at the interface and gives a measure of the adsorption of the compound. The addition of EO caused a significant improvement in the adsorption at R max of all the surfactant formulations i.e. caused significant decrease in the value of static surface tension attained (P B 0.05 using Mann -Whitney U test, n =8). However, the addition of EO was detrimental to the stability of most surfactants except PG and PCPE.
An improvement in stability and minimum surface tension were also obtained in the case of PCPEEO. Table 1 summarizes the beneficial effects of EO on the surface properties of the surfactant formulations.
On comparing the surfactant formulations with eucalyptus, and the commercial surfactants, it was observed that PCPEEO performed particularly well with respect to surface tension reduction with significantly lower g min values when compared to Survanta. Its adsorption and stability were also comparable to that of Survanta and it was far superior to ALEC and Exosurf with respect to all the parameters considered. We could not test the re-spreading of Survanta due to technical difficulties in spreading of the aqueous suspension.
The ability of the surfactants to re-spread to the air-liquid interface on dynamic cycling is also a physiologically important parameter. While comparing PCPEEO with that of the therapeutic surfactants, only ALEC and Exosurf were used for comparison, as we were unable to spread the aqueous suspension of Survanta as a chloroform solution at the air-liquid interface of the LB trough. Fig. 5 depicts the performance of PCPEEO with respect to minimum surface ten-sion, stability index, adsorption and re-spreading in comparison with ALEC, Exosurf and Survanta. PCPEEO had a high re-spreading ratio of 0.7290.03 which was higher than that of Exosurf and ALEC (0.18 9 0.02 and 0.65 9 0.03, respectively).
We also compared the ultrastructure of the surfactants in the absence and presence of eucalyptus in a cryogenic scanning electron microscope. The structure of EO alone did not show any membrane formation and had a homogenous stippled appearance of oil micro-droplets in buffer. The surfactants with eucalyptus, formed liposomes, which were easily fractured to reveal their internal membranous organization. Wavy membranous folding was more commonly formed in the case of liposomes containing EO. Fig. 4 . Effect of EO addition on adsorption. The static surface tension at R max is depicted as a measure of adsorption to the air -liquid interface. A lower value of this parameter indicates more efficient adsorption with more surface-active material reaching the interface. All values are means with standard errors with n =5 -8. Table 1 Beneficial effects of EO on surface properties-PBS study The performance of PCPEEO is compared with that of ALEC, Exosurf and Survanta. The minimum surface tension is measured after pulsation at 40 cpm for 30 sec in a pulsating bubble surfactometer. The static surface tension is measured at R max in a pulsating bubble surfactometer as a measure of adsorption. The re-spreading ratio is measured by comparison of the collapse plateau ratios in surface excess films in a Wilhelmy balance. No data was available for the re-spreading of Survanta.
8 mm size, which are fractured revealing the internal wavy layers.
Discussion
The present study found an improvement in the adsorption of surfactants at an air-liquid interface on addition of EO. The effects of EO on minimum surface tension and stability were not consistent for all surfactant formulations. The addition of EO was beneficial consistently only for film adsorption. A beneficial effect on all the parameters studied was observed in the case of PCPEEO when compared with PCPE. This was associated with a decrease in the size of the liposomes on addition of EO (8-10 mm in the case of PCPEEO and 20 -30 mm size in the case of PCPE).
The addition of EO, which contains eucalyptol, as one of its main components, could promote dissolution of large micelle structures and cause fusion of micellar contents. Such properties have been observed in the case of hydrophobic surfactant specific proteins causing more homogenous behavior of phospholipid suspensions (Rana et al., 1993) . A similar phenomenon may account for the improved adsorption of the phospholipids on addition of EO. Microscopically, the surfactants in the presence of EO formed open membranous structures, which could represent this process. This is in accordance with the finding of Sasaki (1990) that open membranous structures are functionally beneficial when compared to closed structures.
The small sized, easily fracturable liposomes of PCPEEO could perhaps account for its superior in vitro performance. This is in partial agreement with the findings of Denizot et al. (1991) that small sonicated liposomes show faster adsorption at an air-liquid interface than the polydisperse larger liposomes. Though our study also found small liposomes of PCPEEO to be functionally beneficial, it did not seem to be a necessity for adequate adsorption. Open membranous structures, regardless of size, appeared to be favorable for adsorption. However, the small size appeared to be related to better surface tension reduction, stability and re-spreading. Fig. 6 (A) depicts a liposome of PCPE whereas Fig. 6 (B) , (C), and (D) depict structures in the presence of EO. Fig. 6 (B) shows a PCEO liposome, which is organized into wavy membranous folds. Similarly, Fig. 6 (C) depicts the partially fractured surface of a liposome of PCPE in the presence of EO and the open membranous organisation of a totally fractured liposome of PCPG in the presence of EO and 5 mM calcium is seen in Fig. 6 (D) . On comparing the ultrastructure of PCPE and PCPEEO, it was observed that PCPE formed large smooth liposomes 20-30 mm in size whereas PCPEEO formed small liposomes barely PCPEEO was found to be comparable to Survanta in vitro with respect to surface tension reduction and was superior to ALEC and Exosurf with respect to all parameters compared -minimum surface tension, stability index and adsorption at R max . It also had a high re-spreading ratio, as detected by the Wilhelmy balance study, comparable to that of ALEC and Exosurf. The improved adsorption and re-spreading, if extended to in vivo conditions, could help in development of a more efficient surfactant formulation which could adsorb quickly to the air -liquid interface of the lungs and prevent collapse of the lungs by lowering of surface tension. The improved respreading would allow re-entry of surfactant material into the interface with subsequent breaths preventing a depletion of material from the interface due to losses. Further, the surface tension of PC with EO and of PCPE with EO on adsorption at R max was B 25 mN/m, which is similar to the values observed for lung surfactant and its reconstituted components (Ingenito et al., 2000) . The presence of EO could perhaps help in the re-entry of extra surfactant material from the surface associated reservoir into the interface on expansion. It appears that PCPEEO may hold potential as a possible surfactant formulation.
However, we have not studied the compressibility of the first compression monolayers in the presence of EO, another important parameter for effective function. Further studies in a leak free captive bubble surfactometer would be informa- tive in this regard. Thus, the addition of EO (1%) to PCPE (2:3) resulted in a favorable surfactant formulation in vitro. It was found to be a promising candidate for possible exogenous surfactant therapy in RDS based on its in vitro properties. It is to be remembered that in vitro studies do not necessarily provide an accurate determination of in vivo exogenous surfactant efficacy due to inhibitory effects of plasma proteins, the in vivo metabolism of the exogenously administered surfactant and inability to model the complex environment of the lungs in vitro. Thus, one must be cautious while extending these findings to in vivo conditions. Further research in the form of animal trials is required. Also, EO has never been used in neonates and its safety remains to be established. Though very low doses have been of EO have been used in this study, far below the doses described to have toxic effects -2 -5 ml (Tibballs, 1995; Day et al., 1997) and Webb and Pitt (1993) failed to find any toxic effects in children under 14 yr age even on oral ingestion of more than 30 ml of the oil, this requires to be further confirmed.
In the event of its success in animal trials and its passing the toxicity tests, PCPEEO could be a promising surfactant formulation, which would be inexpensive and could be beneficial to many babies in developing countries who are otherwise unable to afford the present day surfactants.
